iPSC-derived CAR-NK extracellular vesicles for non-small cell lung cancer: evidence, engineering, and translational barriers
Non-small cell lung cancer (NSCLC) remains difficult to treat with adoptive cell therapies because of antigen heterogeneity, immunosuppressive tumor microenvironments, stromal barriers, and manufacturing variability. Direct evidence for iPSC-derived CA…